![Scott Phillips](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Phillips
Geen lopende functies
Loopbaan van Scott Phillips
Eerdere bekende functies van Scott Phillips
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biohaven Pharmaceuticals, Inc.
![]() Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Financieel Directeur/CFO | 13-11-2017 | 01-11-2018 |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 13-11-2017 | 01-11-2018 |
ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - | - |
Opleiding van Scott Phillips
The University of North Carolina at Charlotte | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Comptroller/Controller/Auditor | 1 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
![]() Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Biohaven Pharmaceuticals, Inc.
![]() Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
- Beurs
- Insiders
- Scott Phillips
- Ervaring